Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD

NCT03059849 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of funding

Conditions

Crohn Disease
Ulcerative Colitis

Interventions

DRUG: Adalimumab

Sponsor

McMaster University